	Repurposing Old Drugs: Roflumilast as a Promising Therapeutic Option for Plaque Psoriasis. Clin Cosmet Investig Dermatol Li S, Wu N, Liu X, Jiang W. PMID: 42405325 [PubMed - in process]
	Investigating the relationship between psoriatic arthritis, multiple long-term conditions, treatment burden and adverse clinical outcomes: A systematic review protocol. J Multimorb Comorb Opoku-Pare GA, Jani BD, Siebert S, Mair FS, Booth I, Canning J, Nicholl BI. PMID: 42404215 [PubMed - in process]
	A Systematic Literature Review on Methotrexate Hepatotoxicity in Psoriasis Management: Preconceived Notion or Real Threat? Acta Derm Venereol Boehncke WH, Constantin MM, Carrascosa-Carrillo JM, Rakvit P, Varlet AA, Le Clanche S, Verhagen LAW, Viguier M. PMID: 42403312 [PubMed - indexed for MEDLINE]
	Comparative Transcriptomics Reveals SKH-1 Mice as a Valuable Model for Psoriasis Pathogenesis and Recurrence Studies. Exp Dermatol Yue L, Bai Y, Pang B, Qiao P, Xue K, Hu L, Wang G, Dang E. PMID: 42402932 [PubMed - indexed for MEDLINE]
	Comparative risk of reactivation of hepatitis B and C after treatment with biologics and targeted synthetic DMARDs in psoriasis and psoriatic arthritis: a 15-year multicenter cohort study. J Am Acad Dermatol Xue Y. PMID: 42398781 [PubMed - as supplied by publisher]
	Interpreting Radiographic Outcomes Across IL-23 Inhibitor Trials in Psoriatic Arthritis: The Role of Trial Design. J Am Acad Dermatol Oberlin D, Veenstra J. PMID: 42398773 [PubMed - as supplied by publisher]
	Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials. Br J Dermatol Stein Gold L, Armstrong AW, Soung J, Vender RB, González Cantero Á, Hoffmann M, Guenthner ST, Hong HC, Murrell DF, Song EJ, Kircik L, Augustin M, Sauder M, Gerdes S, Reyes-Servin O, Edem BE, Campbell J, Cresswell K, Kephart L, Li S, Yang YW, Bissonnette R. PMID: 42397072 [PubMed - as supplied by publisher]
	Ustekinumab Biosimilars versus Reference Ustekinumab for Moderate-to-Severe Plaque Psoriasis: A Pre-switch Systematic Review and Meta-analysis. BioDrugs Montes-de-Oca-Saucedo CR, Ghanem L, Kirmani N, Briceño-Villardaga B, Talancon-Solana AM, Salinas-Ocampo AJ, Sereno-Acevedo G, Soto-Domínguez A, Rivera-Díaz R. PMID: 42393486 [PubMed - as supplied by publisher]
	Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis. Dermatol Ther (Heidelb) Crowley J, Song EJ, Stein-Gold L, Gisondi P, Bunick CG, Garg V, Leoncini E, Kaplan B, Ta R, Truong B, Sharma D, Strober B. PMID: 42393457 [PubMed - as supplied by publisher]
	Immunobiological Therapy in Moderate-to-Severe Psoriasis: A Retrospective Cohort Study Investigating the Effects of Inadequate Therapeutic Compliance on Drug Survival. Dermatol Ther (Heidelb) Ribeiro LA, Kurizky PS, de Sena RR, Fares S, Dos Santos GBF, Galvão LO, da Mota LMH, Gomes CM. PMID: 42390709 [PubMed - as supplied by publisher]
	Clinical Characteristics, Healthcare Resource Utilization, and Costs of Patients with Generalized Pustular Psoriasis in Taiwan: A National Claims Database Study. Psoriasis (Auckl) Chien HT, Tseng CY, Lu CW, Chung WH, Lin FJ. PMID: 42389669 [PubMed]
	Modified Delphi Consensus Recommendations for the Management of Psoriasis in Asia-Pacific. Dermatol Ther (Heidelb) Baek YS, Choon SE, Foley PA, Tsai TF, Zhang J, Yamaguchi Y. PMID: 42387165 [PubMed - as supplied by publisher]
	Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at WeekÂ 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two PhaseÂ III Trials. Dermatol Ther (Heidelb) Esposito M, Morón-Ocaña JM, Gupta AK, Galván J, Bentohami A, Freischläger F. PMID: 42387164 [PubMed - as supplied by publisher]
	Bimekizumab Improves Health Status and Work Productivity, With Reduced Productivity Costs, to 3 Years in Axial Spondyloarthritis and Psoriatic Arthritis. J Rheumatol Nikiphorou E, Tillett W, Deodhar A, Dubreuil M, Gossec L, Hwang M, Lubrano E, Machado PM, Rudwaleit M, de Wit M, Kavanagh S, de la Loge C, Ink B, Healy P, Lambert J, Mørup M, Boonen A, Walsh J. PMID: 42386286 [PubMed - as supplied by publisher]
	Do Patients Diagnosed with Psoriatic Arthritis Before or Concurrently with Psoriasis Have Different Disease Phenotype and Outcomes? J Rheumatol Anacleto-Dabarno M, Kharouf F, Carrizo Abarza V, Mehta P, Gao S, Pereira D, Cook RJ, Poddubnyy D, Chandran V, Gladman DD. PMID: 42386278 [PubMed - as supplied by publisher]
	Psoriatic Disease Across Dimensions: Global Epidemiology, Comorbidity, and Artificial Intelligence in Treatment Prediction. J Rheumatol Koppikar S, Rodríguez-Zúñiga M, Dua D, Mathew AJ. PMID: 42386277 [PubMed - as supplied by publisher]
	Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST. Rheumatology (Oxford) Coates LC, Gladman DD, Merola JF, Mrowietz U, Armstrong A, Baraliakos X, Tillett W, Kishimoto M, Reddy J, Teng L, Amouzadeh H, Deignan C, Mease PJ, Gossec L. PMID: 42384964 [PubMed - as supplied by publisher]
	Arterial stiffness in patients with moderate to severe psoriasis on long term treatment with infliximab. BMC Cardiovasc Disord Hagenes JS, Linde A, Tveit KS, Kringeland E, Midtbø H. PMID: 42380859 [PubMed - as supplied by publisher]
	Predicting psoriatic arthritis in new-onset psoriasis: development of multivariable prediction models from an inception cohort study. Lancet Rheumatol Svedbom A, Mallbris L, Zabotti A, Playford MP, Nikamo P, Mehta NN, Ståhle M. PMID: 42379214 [PubMed - as supplied by publisher]
	Efficacy and safety of Tripterygium agents in treatment of psoriasis: a systematic review and network meta-analysis. Phytomedicine Lin NX, He JJ, Gao PB, Zhang M, Cao RQ, Sun XY, Zhou YQ, Wang J, Cai XC, Li LH, Yeap JW, Yu YT, Gheyret N, Ling YJ, Jie CX, Li B, Li X, Liu L. PMID: 42378804 [PubMed - as supplied by publisher]

Articles 1 - 20 / 28171

Page 1 of 1409



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy